Influence of Yifeiqinghua Granules on Expression of Vascular Endothelial Growth Factors and Its Receptor KDR in Lewis Lung Cancer Mice
10.3969/j.issn.1005-5304.2013.12.011
- VernacularTitle:益肺清化颗粒对Lewis肺癌小鼠血管内皮细胞生长因子及其受体的影响
- Author:
Feifei LI
;
Hao WU
;
Lu CHEN
;
Bin ZHOU
- Publication Type:Journal Article
- Keywords:
Yifeiqinghua granules;
lung cancer;
VEGF;
VEGF receptor;
mice
- From:
Chinese Journal of Information on Traditional Chinese Medicine
2013;(12):29-31
- CountryChina
- Language:Chinese
-
Abstract:
Objective To clarify the mechanism of Yifeiqinghua granules on tumor angiogenesis and tumor inhibition by observing its influence on the expression of vascular endothelial growth factor (VEGF) and its receptor KDR in Lewis lung cancer mice. Methods Eighty C57BL/6 inbred mice subcutaneously planted with Lewis tumor cell suspension 0.2 mL were randomly divided into 8 groups:blank group, control group, low-, medium- and high-dose of Yifeiqinghua granules groups, Gefitinib group, Gefitinib plus medium-dose of Yifeiqinghua granules group and CTX group, 10 mice in each group. Drugs were administrated from the second day. CTX group was administered on third day and seventh day, other groups were administered for 14 days. The mice were killed to take the tumor on the 15th days. VEGF and KDR expression in tumor tissue was measured by Western Blot. Results Compared with the blank group, the expression of VEGF was significantly decreased in the low- and medium-dose of Yifeiqinghua granules groups (P<0.01). Gefitinib group’s VEGF value was lower than the blank group (P<0.05). Compared with the blank group, the expression of VEGF was significantly decreased in the high-dose of Yifeiqinghua granular group, Gefitinib plus medium-dose of Yifeiqinghua granules group and CTX group (P<0.001). Compared with the blank group, the expression of KDR was significantly decreased in the low-, medium- and high-dose of Yifeiqinghua granules groups, Gefitinib group and CTX group (P<0.05). Conclusions The possible mechanism of Yifeiqinghua granules in treating non-small cell lung cancer is reducing the expression of VEGF and KDR, thus play an inhibitory effect.
